Cargando…
Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment
Evaluation of cancer therapy with imaging is crucial as a surrogate marker of effectiveness and survival. The unique response patterns to therapy with immune-checkpoint inhibitors have facilitated the revision of response evaluation criteria using FDG-PET, because the immune response recalls reactiv...
Autores principales: | Oriuchi, Noboru, Endoh, Hideki, Kaira, Kyoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409366/ https://www.ncbi.nlm.nih.gov/pubmed/36012657 http://dx.doi.org/10.3390/ijms23169394 |
Ejemplares similares
-
Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy
por: Oriuchi, Noboru, et al.
Publicado: (2020) -
The role of [(18)F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors
por: Kaira, Kyoichi, et al.
Publicado: (2011) -
Pulmonary “Finger-in-glove” Sign on Fluorodeoxyglucose-positron Emission Tomography
por: Yanagisawa, Satoru, et al.
Publicado: (2019) -
Transcriptomics in cancer revealed by Positron Emission Tomography radiomics
por: Tixier, Florent, et al.
Publicado: (2020) -
Effects of alterations in positron emission tomography imaging parameters on radiomics features
por: Ger, Rachel B., et al.
Publicado: (2019)